CH622811A5 - - Google Patents
Download PDFInfo
- Publication number
- CH622811A5 CH622811A5 CH392475A CH392475A CH622811A5 CH 622811 A5 CH622811 A5 CH 622811A5 CH 392475 A CH392475 A CH 392475A CH 392475 A CH392475 A CH 392475A CH 622811 A5 CH622811 A5 CH 622811A5
- Authority
- CH
- Switzerland
- Prior art keywords
- methyl
- chloro
- fluoro
- carboxylic acid
- acid
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J17/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, having an oxygen-containing hetero ring not condensed with the cyclopenta(a)hydrophenanthrene skeleton
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J5/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond
- C07J5/0046—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa
- C07J5/0061—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa substituted in position 16
- C07J5/0069—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa substituted in position 16 by a saturated or unsaturated hydrocarbon group
- C07J5/0076—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa substituted in position 16 by a saturated or unsaturated hydrocarbon group by an alkyl group
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J7/00—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms
- C07J7/0005—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21
- C07J7/001—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by a keto group
- C07J7/004—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by a keto group substituted in position 17 alfa
- C07J7/005—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by a keto group substituted in position 17 alfa substituted in position 16
- C07J7/0055—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by a keto group substituted in position 17 alfa substituted in position 16 by a saturated or unsaturated hydrocarbon group
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J7/00—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms
- C07J7/008—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms substituted in position 21
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Rheumatology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Pain & Pain Management (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Steroid Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PT6163674 | 1974-03-27 | ||
| PT6163774 | 1974-03-27 | ||
| PT6163675 | 1975-03-10 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CH622811A5 true CH622811A5 (fr) | 1981-04-30 |
Family
ID=27354092
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CH392475A CH622811A5 (fr) | 1974-03-27 | 1975-03-26 | |
| CH946879A CH625254A5 (fr) | 1974-03-27 | 1979-10-22 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CH946879A CH625254A5 (fr) | 1974-03-27 | 1979-10-22 |
Country Status (8)
| Country | Link |
|---|---|
| BE (1) | BE827275A (fr) |
| CH (2) | CH622811A5 (fr) |
| DK (1) | DK153556C (fr) |
| FR (1) | FR2274309A1 (fr) |
| GB (2) | GB1510617A (fr) |
| IE (2) | IE41138B1 (fr) |
| NZ (1) | NZ177056A (fr) |
| SE (1) | SE440656B (fr) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR890000664B1 (ko) * | 1981-10-19 | 1989-03-22 | 바리 안소니 뉴우샘 | 미분된 베클로메타손 디프로피오네이트 일수화물의 제조방법 |
| IT1285770B1 (it) | 1996-10-04 | 1998-06-18 | Nicox Sa | Composti corticoidei |
| CN102516348B (zh) * | 2011-11-10 | 2013-11-13 | 中国科学院上海有机化学研究所 | 一种16s-甲基-20s-羟基孕甾化合物、合成方法及其用途 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB1070751A (en) * | 1964-01-28 | 1967-06-01 | Glaxo Lab Ltd | 17-esters of 17-hydroxy-21-desoxy-steroids |
| GB1139505A (en) * | 1965-06-23 | 1969-01-08 | Glaxo Lab Ltd | A process for the production of 17-‡-monoesters of 17-‡-hydroxy-20-keto-steroids |
| CH481085A (de) * | 1965-08-30 | 1969-11-15 | Scherico Ltd | Verfahren zur Herstellung von 11B-Hydroxy-17 -alkanoyloxysteroiden der Pregnanreihe |
| US3383394A (en) * | 1965-08-30 | 1968-05-14 | Schering Corp | Novel 17-acylating process and products thereof |
| BE788355A (fr) * | 1971-09-07 | 1973-03-05 | Merck Patent Gmbh | Esters de 9 alpha-fluoro-16-methylene-prednisolone |
-
1975
- 1975-03-26 CH CH392475A patent/CH622811A5/de not_active IP Right Cessation
- 1975-03-26 DK DK129575A patent/DK153556C/da not_active IP Right Cessation
- 1975-03-26 GB GB12608/75A patent/GB1510617A/en not_active Expired
- 1975-03-26 GB GB47940/77A patent/GB1511820A/en not_active Expired
- 1975-03-26 NZ NZ177056A patent/NZ177056A/xx unknown
- 1975-03-27 IE IE2062/75A patent/IE41138B1/xx unknown
- 1975-03-27 IE IE693/75A patent/IE41137B1/xx unknown
- 1975-03-27 FR FR7509621A patent/FR2274309A1/fr active Granted
- 1975-03-27 BE BE154849A patent/BE827275A/fr not_active IP Right Cessation
-
1978
- 1978-03-16 SE SE7803041A patent/SE440656B/sv not_active IP Right Cessation
-
1979
- 1979-10-22 CH CH946879A patent/CH625254A5/de not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| DK153556C (da) | 1988-12-05 |
| GB1510617A (en) | 1978-05-10 |
| IE41137B1 (en) | 1979-10-24 |
| SE440656B (sv) | 1985-08-12 |
| GB1511820A (en) | 1978-05-24 |
| DK153556B (da) | 1988-07-25 |
| FR2274309A1 (fr) | 1976-01-09 |
| CH625254A5 (fr) | 1981-09-15 |
| FR2274309B1 (fr) | 1978-11-24 |
| DK129575A (fr) | 1975-09-28 |
| IE41137L (en) | 1975-09-27 |
| BE827275A (fr) | 1975-07-16 |
| NZ177056A (en) | 1978-09-20 |
| IE41138B1 (en) | 1979-10-24 |
| SE7803041L (sv) | 1978-03-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE2707336C2 (fr) | ||
| DE2526373C2 (de) | Verfahren zur Herstellung von Δ↑9↑↑(↑↑1↑↑1↑↑)↑-5α-20-Ketosteroiden | |
| CH630394A5 (de) | Verfahren zur herstellung von steroiden. | |
| DE2512915C2 (fr) | ||
| DE1618065C3 (de) | 21-Oxo-23-desoxo-cardenoIide, Verfahren zu deren Herstellung und daraus hergestellte Arzneimittel | |
| CH631462A5 (de) | Verfahren zur herstellung von neuen steroiden der androstan- oder oestranreihe. | |
| CH622811A5 (fr) | ||
| AT357696B (de) | Verfahren zur herstellung von 16alpha- und 16beta-methyl-9alpha-chlor- oder -fluor-21- -desoxyprednisolonestern und -aethern | |
| CH504423A (de) | Verfahren zur Herstellung von 17a-Mono-kohlenwasserstoffcarbonsäureestern von 9a, 11B-Dihalogen-16a-niedrigalkyl-1,4-pregnadien-17a, 21-diol-3,20-dionen und ihren 4-Pregnen-Analoga | |
| DE2852055C2 (fr) | ||
| EP0077541B1 (fr) | Delta-1,3,5-3-chloro-11-bêta, 16-alpha, 17-alpha, 21-tétra-(hydroxy)-pregnane-20-one-16,17-acétonides, procédé pour les préparer et médicaments les contenant | |
| EP0005758B1 (fr) | Procédé de synthèse de la chaîne latérale hydroxy acétylique de stéroides prégnaniques, 21-hydroxy-20-oxo-17alpha prégnanes et préparations pharmaceutiques les contenant | |
| EP0011121B1 (fr) | Esters d'hydrocortisone, compositions pharmaceutiques les contenant et procédé pour leur préparation | |
| DE2365992A1 (de) | 6 alpha-fluor-17,21-dihydroxy-16 beta-methylpregna-4,9(11)-dien-3,20- dion-17,21-diacetat und verfahren zu dessen herstellung | |
| CH616435A5 (fr) | ||
| EP0051597B1 (fr) | Nouveaux derives de prostacycline et leur preparation | |
| DE60112024T2 (de) | Verfahren zur Isomerisierung von 6-Beta-Fluorosteroide zu den entsprechenden 6-Alpha-Derivaten | |
| EP0186834B1 (fr) | 13-Alpha-alcoyle-17-bêta-(3-acyloxy-propyl)-gonane | |
| AT221723B (de) | Verfahren zur Herstellung therapeutisch wertvoller Carbonsäureester von 17-Alkyl-19-nor-testosteronen | |
| AT229497B (de) | Verfahren zur Herstellung von 9-Halogen-1, 4-pregnadien-11-olen | |
| AT368522B (de) | Verfahren zur herstellung von neuen 2,9alpha- | |
| AT232659B (de) | Verfahren zur Herstellung neuer Steroidverbindungen | |
| AT362888B (de) | Verfahren zur herstellung von neuen estern von androstadien-17-carbonsaeuren | |
| AT217645B (de) | Verfahren zur Herstellung von neuen Derivaten des Aldosterons | |
| AT364098B (de) | Verfahren zur herstellung von neuen estern von androstadien-17-carbonsaeuren |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PL | Patent ceased |